Laryngeal Neoplasia

Laryngeal neoplasia refers to the abnormal growth of benign or malignant cells within the larynx, a cartilaginous and muscular organ located at the entrance of the lower respiratory tract. The larynx serves critical functions including airway protection during swallowing, phonation, and regulation of airflow. Neoplasms can arise from epithelial, mesenchymal, or neuroendocrine tissues, leading to structural and functional compromise. Clinically, laryngeal tumors present with progressive respiratory distress, voice changes, dysphagia, and stridor. They are relatively uncommon in dogs and cats, but malignant forms, particularly squamous cell carcinoma and lymphoma, carry a guarded to poor prognosis. Early diagnosis and aggressive treatment are essential for improving outcomes.

The exact etiology of laryngeal neoplasia remains largely unknown, but several factors are implicated. Chronic inflammation, exposure to environmental carcinogens (e.g., tobacco smoke, asbestos), and viral infections (e.g., papillomavirus in dogs) may contribute. In cats, retroviral infections (FeLV, FIV) are associated with lymphoma, which can affect the larynx. Genetic predispositions and breed-specific heritable factors are suspected. For benign tumors, such as rhabdomyoma, a hamartomatous origin is proposed. No single causative agent has been definitively identified, and most cases are considered idiopathic.

Laryngeal neoplasia is rare in both dogs and cats, accounting for less than 1% of all tumors in these species. In dogs, the most common benign tumor is the laryngeal rhabdomyoma, which typically affects young to middle-aged dogs, with a possible predilection for Labrador Retrievers. Malignant tumors, such as squamous cell carcinoma and adenocarcinoma, are more common in older dogs. In cats, lymphoma is the most frequent laryngeal malignancy, often associated with FeLV or FIV infection, and can occur in younger cats. There is no strong sex predilection, though some studies suggest a slight male predominance. No geographic or seasonal patterns have been identified.

Laryngeal tumors disrupt normal airway dynamics by occupying space, causing mechanical obstruction, and infiltrating surrounding tissues. Benign tumors, such as rhabdomyomas, grow slowly and may cause progressive stridor and exercise intolerance. Malignant tumors, particularly squamous cell carcinoma, are locally invasive, destroying the laryngeal cartilages and adjacent structures, leading to severe respiratory distress, dysphagia, and aspiration pneumonia. Lymphoma can cause diffuse thickening of the laryngeal mucosa, resulting in narrowing of the airway. Metastasis to regional lymph nodes and distant organs (lungs, liver) occurs in advanced stages. The tumor's mass effect and inflammatory response contribute to edema, further compromising the airway.

Predisposing factors include age (older animals for malignant tumors), breed (Labrador Retrievers for rhabdomyoma), and viral infections (FeLV/FIV for lymphoma in cats). Chronic exposure to irritants or carcinogens may increase risk. Immunosuppression, either from disease or medication, can predispose to lymphoma. There is no strong evidence for dietary or management factors. Genetic susceptibility is suspected but not well-defined.

Clinical signs vary with tumor type and location. Common signs include progressive inspiratory stridor, dysphonia (voice change), coughing, gagging, dysphagia, and exercise intolerance. As the tumor enlarges, respiratory distress becomes more pronounced, especially during inspiration. In advanced cases, cyanosis, syncope, and collapse may occur. Cats with lymphoma may present with weight loss, anorexia, and lethargy. Physical examination may reveal palpable cervical masses, enlarged mandibular lymph nodes, and auscultation of referred upper airway sounds. In severe obstruction, signs of respiratory failure are evident.

Differential diagnoses include laryngeal paralysis, laryngeal collapse, foreign body, granulomatous laryngitis (e.g., fungal, parasitic), laryngeal cyst, and other benign or malignant tumors. Laryngeal paralysis typically presents with a characteristic inspiratory stridor and can be differentiated by laryngeal examination under light anesthesia. Foreign bodies may cause acute onset of signs and are visible on imaging or endoscopy. Granulomatous diseases, such as blastomycosis or aspergillosis, may mimic tumors and are diagnosed via cytology or histopathology. Laryngeal cysts are rare and appear as fluid-filled structures on imaging. Other tumors, such as chondrosarcoma or osteosarcoma, are less common but must be considered.

The diagnostic approach begins with a thorough history and physical examination, including assessment of respiratory effort and cervical palpation. Baseline bloodwork (CBC, biochemistry, urinalysis) and thoracic radiographs are recommended to rule out metastatic disease and concurrent conditions. Cervical radiographs may reveal soft tissue masses or calcification. Advanced imaging, such as CT or MRI, provides detailed anatomical information and helps assess local invasion and lymph node involvement. Definitive diagnosis requires tissue biopsy, which can be obtained via laryngoscopy-guided biopsy, fine-needle aspiration, or surgical biopsy. Histopathology and immunohistochemistry are essential for tumor typing. In cats, FeLV/FIV testing is recommended if lymphoma is suspected.

Laboratory findings are often nonspecific. CBC may show mild leukocytosis or anemia in chronic disease. Biochemistry may reveal elevated liver enzymes if metastasis is present. In cats with lymphoma, FeLV/FIV tests may be positive. No specific tumor markers are available. Arterial blood gas analysis may show hypoxemia and hypercapnia in severe respiratory compromise. Urinalysis is usually unremarkable.

Radiography: Lateral cervical radiographs may show a soft tissue mass in the laryngeal region, with or without calcification. Thoracic radiographs are essential to detect pulmonary metastasis. Ultrasonography: Can be used to evaluate cervical masses and guide fine-needle aspiration, but is limited by air in the airway. Computed Tomography (CT): Provides excellent detail of the laryngeal anatomy, tumor extent, and invasion into surrounding tissues. It is the preferred imaging modality for surgical planning. Magnetic Resonance Imaging (MRI): Offers superior soft tissue contrast and is useful for assessing neurovascular involvement. Endoscopy: Direct visualization of the larynx via laryngoscopy is crucial for identifying mucosal lesions and obtaining biopsies.

Fine-needle aspiration (FNA) of laryngeal masses can be performed via a percutaneous approach or during laryngoscopy. Cytology may reveal epithelial cells, lymphocytes, or mesenchymal cells, but is often nondiagnostic due to the firm nature of some tumors. Histopathology from biopsy is the gold standard. Benign rhabdomyomas show well-differentiated striated muscle fibers. Squamous cell carcinoma exhibits nests of squamous epithelial cells with keratin pearls and intercellular bridges. Lymphoma is characterized by a monomorphic population of lymphoid cells, often with a high mitotic index. Immunohistochemistry (e.g., cytokeratin, vimentin, CD3, CD79a) helps differentiate tumor types.

Treatment depends on tumor type, stage, and clinical signs. For benign tumors, surgical excision (e.g., partial laryngectomy) may be curative. For malignant tumors, options include surgery (total laryngectomy with permanent tracheostomy), radiation therapy, and chemotherapy. In dogs with squamous cell carcinoma, surgical debulking followed by radiation therapy may provide palliation. Lymphoma is treated with systemic chemotherapy (e.g., CHOP protocol) with or without radiation. Emergency management of respiratory distress may require temporary tracheostomy. Supportive care includes oxygen supplementation, anti-inflammatory doses of corticosteroids (e.g., dexamethasone 0.1-0.2 mg/kg IV), and nutritional support if dysphagia is present.

Prognosis varies widely. Benign tumors, such as rhabdomyoma, have a good to excellent prognosis after complete surgical excision. Malignant tumors, especially squamous cell carcinoma, carry a guarded to poor prognosis due to local recurrence and metastasis. Median survival times for dogs with laryngeal squamous cell carcinoma are reported to be around 6-12 months with aggressive therapy. Cats with laryngeal lymphoma may achieve remission with chemotherapy, with median survival times of 6-12 months. Negative prognostic factors include advanced stage, presence of metastasis, and incomplete surgical margins.

Post-treatment monitoring is essential. For benign tumors, re-examination every 3-6 months for the first year, then annually. For malignant tumors, more frequent monitoring (every 1-3 months) with thoracic radiographs and cervical imaging to detect recurrence or metastasis. Serial laryngoscopy may be needed to assess local recurrence. Bloodwork and quality-of-life assessments are recommended at each visit.

Pearls: Always consider laryngeal neoplasia in older animals with progressive stridor. Use CT for surgical planning. Obtain multiple biopsies to avoid sampling error. In cats, test for FeLV/FIV. Pitfalls: Avoid relying solely on FNA for diagnosis. Do not delay tracheostomy in severe respiratory distress. Be cautious with corticosteroids in lymphoma cases as they may cause tumor lysis. Ensure adequate airway management during anesthesia.

For lymphoma: CHOP protocol (e.g., vincristine 0.7 mg/m² IV, cyclophosphamide 250 mg/m² PO, doxorubicin 30 mg/m² IV, prednisone 2 mg/kg PO q24h) with dose adjustments based on toxicity. For squamous cell carcinoma: Palliative radiation therapy (e.g., 8 Gy once weekly for 4 weeks) may be used. Anti-inflammatory doses of prednisone (0.5-1 mg/kg PO q24h) can reduce peritumoral edema. Antibiotics (e.g., amoxicillin-clavulanate 13.75 mg/kg PO q12h) are indicated if secondary infection is present. Analgesics (e.g., tramadol 2-5 mg/kg PO q8-12h) for pain management.

Literature on laryngeal neoplasia is limited to case series and retrospective studies. A study by Withrow et al. (2007) reported that dogs with laryngeal rhabdomyoma had excellent outcomes after surgery. Another study by MacPhail (2014) noted that cats with laryngeal lymphoma treated with chemotherapy had a median survival of 6 months. ACVIM consensus guidelines on respiratory tumors recommend a multimodal approach for malignant laryngeal tumors. Further research is needed to establish standardized treatment protocols.